| Revenue | SEK 41,6M | +31% |
| EBITDA | SEK 1,4M | +42% |
| Net profit | SEK -3,9M | -378% |
| Total assets | SEK 1,2B | +1% |
| Equity | SEK 490,3M | -1% |
| Employees | — | — |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 7 947 | 11 195 | 18 935 | 36 679 | 28 125 | 31 654 | 41 595 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | −122 | 20 | 379 | 665 | 903 | 655 | 903 | 1 013 | 1 435 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −37 | −112 | −1 098 |
| EBIT | −122 | 20 | 379 | 665 | 903 | 655 | 866 | 901 | 337 |
| Net financials | — | −7 | — | −4 | −301 | −77 250 | −154 812 | −14 471 | −52 255 |
| Profit before tax | −122 | 13 | 379 | 661 | 602 | −16 539 | −20 505 | 1 408 | −1 880 |
| Tax | −0 | −17 | −92 | −153 | −110 | −273 | −126 | −0 | −2 029 |
| Net profit | −122 | −4 | 287 | 508 | 492 | −16 812 | −20 631 | 1 408 | −3 909 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 130 851 | 172 982 | 198 215 | 246 314 | 1 096 970 | 1 144 864 | 1 183 821 | 1 205 870 | 1 216 127 |
| Equity | 130 708 | 171 654 | 197 015 | 244 270 | 530 222 | 513 414 | 492 783 | 494 191 | 490 282 |
| Long-term debt | 0 | 0 | 0 | 0 | 541 732 | 628 529 | 687 553 | 683 337 | 711 053 |
| Short-term debt | 143 | 1 328 | 1 200 | 2 044 | 25 005 | 2 921 | 3 486 | 28 342 | 14 793 |
| Total debt | 143 | 1 328 | 1 200 | 2 044 | 566 737 | 631 450 | 691 039 | 711 679 | 725 846 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EC Chief Auditor | Chief Auditor | 2026 | — | — |
CR Chief Auditor | Chief Auditor | 2020 | — | — |
CT Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2026 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Vimian Pharma Holding AB | Company | 100.0% | 100.0% | 2024 |
| Person | Role here | Other companies |
|---|---|---|
| Eva Camilla Nilsson | Chief Auditor | 0 companies |
| Carl-Johan Regell | Chief Auditor | 0 companies |
| Carl-Johan T Zetterberg Boudrie | Chief Executive Officer | 0 companies |
| Alireza Tajbakhsh | Chairman | 0 companies |
| Carl Gabriel Lindsay Fitzgerald | Deputy Board Member | 0 companies |
| Viktor Carl-Oscar Luthman | Board of Directors | 0 companies |
| Carl Erik Andreas Lidman | Deputy Board Member | 0 companies |
| Carl Fredrik Michael Ullman | Chairman | 0 companies |
| Theodor Simon Josef Bonnier | Board of Directors | 0 companies |
| Karl Anders Johansson | Board of Directors | 0 companies |
| Erik Gunnar Öhlén | Board of Directors | 0 companies |
| Sven Johan Magnus Göte Kjellberg | Chairman | 0 companies |
| Martin Nilsson Erleman | Chairman | 0 companies |
| Fredrik Aitor Svedberg | Board of Directors | 0 companies |